These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 13419224)

  • 41. Outcome in obstetric care related to oxytocin use. A population-based study.
    Oscarsson ME; Amer-Wåhlin I; Rydhstroem H; Källén K
    Acta Obstet Gynecol Scand; 2006; 85(9):1094-8. PubMed ID: 16929414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Survey of the practice of cervical ripening and labor induction in France].
    Goffinet F; Dreyfus M; Carbonne B; Magnin G; Cabrol D
    J Gynecol Obstet Biol Reprod (Paris); 2003 Nov; 32(7):638-46. PubMed ID: 14699333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormonal control of labor with relaxin and oxytocin.
    EISENBERG L
    J Am Osteopath Assoc; 1958 Jul; 57(11):702-5. PubMed ID: 13563238
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of synthetic oxytocin during labor].
    WICINSKI R; JASKIEWICZ J; LATOCHA W; WISZNIEWSKA A; WISZNIEWSKI R; ZASZTOWT O; OLEJEWSKA Z
    Praxis; 1958 Mar; 47(10):245-8. PubMed ID: 13542436
    [No Abstract]   [Full Text] [Related]  

  • 45. High- versus low-dose oxytocin for augmentation or induction of labor.
    Patka JH; Lodolce AE; Johnston AK
    Ann Pharmacother; 2005 Jan; 39(1):95-101. PubMed ID: 15572602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double blind, randomized trial on augmentation of labour with a combination of intravenous propranolol and oxytocin versus oxytocin only.
    Palomäki O; Uotila J; Tammela O; Kaila T; Lavapuro M; Huhtala H; Tuimala R
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):44-9. PubMed ID: 16051416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of labor in great grandmultipara with misoprostol.
    Zeteroglu S; Sahin HG; Sahin HA
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):27-32. PubMed ID: 16129547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Currently used oxytocin regimen outcome measures at term & postterm. I: Outcome indicators in relation to parity & indication for induction.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):235-42. PubMed ID: 18330323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Currently used oxytocin regimen outcome measures at term & postterm. II: Outcome indicators in relation to Bishop Score & other covariates.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):243-50. PubMed ID: 18330324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends and controversies in labor induction.
    Moleti CA
    MCN Am J Matern Child Nurs; 2009; 34(1):40-7; quiz 48-9. PubMed ID: 19104318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical induction using intravenous pitocin.
    SWITZER DM
    Miss Doct; 1952 Jan; 29(8):187-9. PubMed ID: 14910395
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of a synthetic oxytocin in drug-induced labor].
    VELIKAY L
    Zentralbl Gynakol; 1957 Jun; 79(22):846-53. PubMed ID: 13457187
    [No Abstract]   [Full Text] [Related]  

  • 53. Prospective randomized study of oxytocin discontinuation after the active stage of labor is established.
    Ustunyurt E; Ugur M; Ustunyurt BO; Iskender TC; Ozkan O; Mollamahmutoglu L
    J Obstet Gynaecol Res; 2007 Dec; 33(6):799-803. PubMed ID: 18001445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of uterine rupture in labor induction of patients with prior cesarean section: an inner city hospital experience.
    Lin C; Raynor BD
    Am J Obstet Gynecol; 2004 May; 190(5):1476-8. PubMed ID: 15167874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison between the effect of oxytocin only and oxytocin plus propranolol on the labor (a double blind randomized trial).
    Kashanian M; Fekrat M; Zarrin Z; Ansari NS
    J Obstet Gynaecol Res; 2008 Jun; 34(3):354-8. PubMed ID: 18588611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of oral and vaginal misoprostol for induction of labor.
    Uludag S; Salihoglu Saricali F; Madazli R; Cepni I
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):57-60. PubMed ID: 15951101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxytocin as a high-alert medication: implications for perinatal patient safety.
    Simpson KR; Knox GE
    MCN Am J Matern Child Nurs; 2009; 34(1):8-15; quiz 16-7. PubMed ID: 19104313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early postpartum hemorrhage after induction of labor.
    Schott K; Anderson J
    J Midwifery Womens Health; 2008; 53(5):461-6. PubMed ID: 18761300
    [No Abstract]   [Full Text] [Related]  

  • 60. Synthetic oxytocin.
    WHITELAW MJ; CARSEN AJ; SANFILIPPO P
    Med Times; 1959 May; 87(5):681-4. PubMed ID: 13656066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.